4/14
11:10 am
anvs
Annovis Bio (ANVS) had its "buy" rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $17.00 price target on the stock.
Low
Report
Annovis Bio (ANVS) had its "buy" rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $17.00 price target on the stock.
4/10
08:30 am
anvs
Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission
Low
Report
Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer's Disease 6-Month NDA Submission
4/9
08:30 am
anvs
Annovis Announces $10 Million Underwritten Offering of Common Stock and Accompanying Warrants
High
Report
Annovis Announces $10 Million Underwritten Offering of Common Stock and Accompanying Warrants
4/2
07:30 am
anvs
Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections
Medium
Report
Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections
3/31
12:31 pm
anvs
InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Highlights Buntanetap Development in The Scientist Publication [TheStreet.com]
Low
Report
InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Highlights Buntanetap Development in The Scientist Publication [TheStreet.com]
3/31
08:00 am
anvs
Annovis Publishes Historical Review of Buntanetap in The Scientist
High
Report
Annovis Publishes Historical Review of Buntanetap in The Scientist
3/19
08:10 pm
anvs
NeuroRPM to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio's Parkinson's Disease Clinical Trial [Yahoo! Finance]
Low
Report
NeuroRPM to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio's Parkinson's Disease Clinical Trial [Yahoo! Finance]
3/19
07:30 am
anvs
Annovis Partners with NeuroRPM to Deploy AI-Powered Digital Biomarker Technology in Parkinson's Disease Study
Medium
Report
Annovis Partners with NeuroRPM to Deploy AI-Powered Digital Biomarker Technology in Parkinson's Disease Study
3/19
07:30 am
anvs
NeuroRPM to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio's Parkinson's Disease Clinical Trial
Medium
Report
NeuroRPM to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio's Parkinson's Disease Clinical Trial
3/16
07:30 am
anvs
Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results
High
Report
Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results
3/3
08:21 am
anvs
Annovis Announces Two Presentations at the AD/PD™ 2026 International Conference [Yahoo! Finance]
Low
Report
Annovis Announces Two Presentations at the AD/PD™ 2026 International Conference [Yahoo! Finance]
3/3
08:00 am
anvs
Annovis Announces Two Presentations at the AD/PD™ 2026 International Conference
Low
Report
Annovis Announces Two Presentations at the AD/PD™ 2026 International Conference
2/12
08:00 am
anvs
Annovis Secures DSMB Approval to Advance Pivotal Phase 3 Trial of Buntanetap in Alzheimer’s Disease
Low
Report
Annovis Secures DSMB Approval to Advance Pivotal Phase 3 Trial of Buntanetap in Alzheimer’s Disease